Validated for Western Blot (WB) and ELISA:
| Application | Recommended Dilution | Validated Samples |
|---|---|---|
| Western Blot | 1:1000–1:4000 | Mouse/Rat small intestine tissue |
| ELISA | Not specified | Human samples |
Detects endogenous OSTA in small intestine tissues, critical for studying bile acid transport .
Specificity confirmed via immunoblotting with minimal cross-reactivity .
OSTA forms a heterodimer with OSTB to mediate cellular uptake of bile acids, steroids, and other organic solutes. Dysregulation is linked to metabolic disorders and cholestasis.
Transmembrane domains: Facilitate solute transport across membranes.
Extracellular loops: Potential sites for ligand interaction .
While OSTA-3 Antibody (31330-1-AP) is specific to SLC51A, other antibodies in oncology (e.g., anti-HER2 OST-HER2 or anti-LAG-3 antibodies ) target distinct pathways.
Current Gaps: Limited in vivo data on OSTA antibody therapeutic potential.
Opportunities:
Mechanistic studies on OSTA/OSTB interaction in disease models.
Expansion into immunohistochemistry (IHC) or flow cytometry applications.
KEGG: cel:CELE_W01D2.5
UniGene: Cel.14239